Timeline for acquisition of PXS‐4728A by BI
21 Jan 2015 Ph1 trial commencement
7 wks later - 12 March 2015 BI Option to aquire
4 wks later - 7 April 2015 +ve prelim results of Ph1
6 wks later - 18 May 2015 BI aquire PXS‐4728A
with Loxl2 Ph1 starting Q4 17 could have 2nd drug sold to big pharma very early 2018 (if trial goes well).
Yet the SP sinks.
